ICVTS Click here for other ICVTS advertising opportunities
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Interact CardioVasc Thorac Surg 2006;5:179-182. doi:10.1510/icvts.2005.121152
© 2006 European Association of Cardio-Thoracic Surgery

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Fumikazu Nomura
Tadashi Isomura
Taiko Horii
Hisayoshi Suma
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nomura, F.
Right arrow Articles by Suma, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nomura, F.
Right arrow Articles by Suma, H.
Related Collections
Right arrow Congestive Heart Failure
Right arrow Coronary disease
Right arrow Myocardial infarction

Institutional report - Coronary

Efficacy of left ventricular restoration with mitral valve surgery for endstage ischemic cardiomyopathy{star}

Fumikazu Nomuraa,*, Tadashi Isomuraa, Taiko Horiia, Hiroshi Iriea, Joji Hoshinoa, Haruka Makinaea and Hisayoshi Sumab

a Cardiovascular Surgery, Hayama Heart Center, 1898 Shimoyamaguchi Hayama, Kanagawa, 240-0116, Japan
b The Cardiovascular Institute, Tokyo, Japan

*Corresponding author: Fax: +81-46-875-3636.

E-mail address: nomura{at}hayamaheart.gr.jp (F. Nomura).

Patients with ischemic cardiomyopathy (ICM) are at an extremely high risk of death and ischemic events. This study aims to evaluate the impact of left ventricular restoration (LVR) and mitral valve surgery on the cardiac and clinical functional status of the patients with ICM. Twenty-six patients (46–80 years, mean: 64 years) with severely dilated heart (left ventricular end-systolic volume index: LVESVI ≥100 ml/m2) who had coronary artery bypass grafting (2.8±1.3), mitral valve surgery, and LVR were enrolled in this study. Left ventricular end-diastolic volume index and LVESVI significantly decreased (from 169±44 to 130±41 ml/m2, P=0.0005, from 120±33 to 89±43 ml/m2, P=0.0012). Left ventricular ejection fraction showed no change. MR showed significant improvement (from 2.7±0.6 to 1.0±0.4, P<0.0001) and NYHA functional class showed improvement (from 3.2±0.8 to 1.5±0.9, P<0.0001). A 5-year survival rate was 71.2%. In conclusion, this aggressive approach with LVR aiming to treat end-stage ICM by relief of ischemia, reduction of LV wall tension by decreasing LV volume and stopping mitral leak, is effective for LV volume reduction and improvement of clinical functional status.

Key Words: Ischemic mitral regurgitation; Left ventricular restoration; Ischemic cardiomyopathy; Mitral valve annuloplasty







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2006 European Association for Cardio-thoracic Surgery